- Home
- MTCH vs ARWR Comparison
MTCH vs ARWR Comparison
Compare MTCH & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTCH | ARWR |
|---|---|---|
| Founded | 1986 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 10.2B |
| IPO Year | 2004 | 2009 |
Fundamental Metrics
Financial Performance| Metric | MTCH | ARWR |
|---|---|---|
| Price | $39.26 | $86.44 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 10 |
| Target Price | $35.17 | ★ $83.40 |
| AVG Volume (30 Days) | ★ 3.6M | 1.8M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.16% | N/A |
| EPS Growth | 17.82 | ★ 99.80 |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $3,487,197,000.00 | $16,142,321.00 |
| Revenue This Year | $2.15 | N/A |
| Revenue Next Year | $3.82 | N/A |
| P/E Ratio | $55.37 | ★ N/A |
| Revenue Growth | ★ 0.22 | N/A |
| 52 Week Low | $28.81 | $14.30 |
| 52 Week High | $39.20 | $87.83 |
Technical Indicators
Market Signals| Indicator | MTCH | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 66.35 | 66.99 |
| Support Level | $29.86 | $70.05 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.21 | 4.09 |
| MACD | 0.33 | 0.66 |
| Stochastic Oscillator | 89.32 | 87.88 |
Price Performance
Historical ComparisonAbout MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. It generates the majority of its revenue from the Tinder segment.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.